Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by PLITheOneon Apr 08, 2021 12:10pm
111 Views
Post# 32957027

RE:what is imminent:

RE:what is imminent:

Imminent!?? You clown, you really have no idea what's going on or don't want to know what's going on. The only thing that's imminent is that the truth is going to come out. Your misleading post don't fool the thousands of people that know how this game is being played. Wait for it, it's coming! Choo choo  


Newcamo wrote: 1- FDA riplazym approval 2- riplazym distribution deal 3- priority voucher potentially worth 100million$ or more...

 

 FDA already reviewed riplazym and it was no problem, only asked for aditional check points... i think this time we'll get it!  LMNL also hired a quality assurance specialist moira daniels, i bet to please the FDA.

 

conference call info from days ago

" I think it's without giving anything away on what we're doing with negotiations and discussions that would be commercially sensitive. The reality is that we are looking at all opportunities here, whether we do this before or after Ryplazim approval. "<<<< =================

 

incoming........$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

=================================================================

 

confirmed as well on latest NR

PDUFA target action date of June 5, 2021 for Ryplazim

"2021 has the potential to be a transformative one for Liminal BioSciences as we progress our evaluation of strategic alternatives for our plasma-derived therapeutics business, while continuing to work towards the PDUFA target action date of June 5, 2021 for Ryplazim ® (plasminogen)," stated Patrick Sartore , President of Liminal BioSciences.
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++

 yes, riplazym on its way to be partnered before or after APPROVAL. (conference call  days ago). And on FDA green light alone, present market cap 120m$  will at least triple.




<< Previous
Bullboard Posts
Next >>